Salzgitter Aktiengesellschaft

  • WKN: 620200
  • ISIN: DE0006202005
  • Land: Deutschland

Nachricht vom 18.08.2020 | 10:01

Salzgitter Aktiengesellschaft: Salzgitter AG expands product range to include green strip steel

DGAP-News: Salzgitter Aktiengesellschaft / Key word(s): Product Launch
18.08.2020 / 10:01
The issuer is solely responsible for the content of this announcement.

Before the end of this year 2020, Salzgitter AG will be able to offer its customers a range of green strip steel products in specified grades and dimensions. The company is moving promptly to take account of the vibrant interest being expressed in these materials. These products will feature a CO2 footprint less than a quarter that of previous steels. In order to enable production, one of the two continuous casting lines at the Peine steelworks will be fitted out to cast slabs.

As Executive Board Chairman Professor Heinz Jörg Fuhrmann commented: "For self-evident technological reasons, high-quality strip steel products fall within the domain of integrated steelworks. Our pioneering SALCOS project is aiming to move step by step towards low-CO2 hydrogen-based metallurgy. In a few months' time, we will be marking another milestone on this journey with the arrival of the first green strip steel. For a large number of our customers, it is important to take delivery of a real, physical reduced-CO2 product, rather than being satisfied with more or less theoretical projections of receiving products with reduced CO2 footprints. We are delighted to be able to meet these demands within a short period of time."


Markus Heidler

Head of Investor Relations

Salzgitter AG
Eisenhüttenstraße 99
38239 Salzgitter

Phone +49 5341 21-6105
Fax +49 5341 21-2570

18.08.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021